
Charles Schwab (SCHW): Asset Gathering Drives the Buy Case
Charles Schwab posted strong 2Q26 growth with adjusted EPS up 42% and core net new assets of $260B. The stock is a Buy, but valuation and rate sensitivity still limit upside.
Everything tagged "interest rates" across the TickerSpark archives.

Charles Schwab posted strong 2Q26 growth with adjusted EPS up 42% and core net new assets of $260B. The stock is a Buy, but valuation and rate sensitivity still limit upside.

A softer July PCE report could revive duration, but the best rebound candidates are profitable, catalyst-backed biotechs rather than every cash-burning growth stock. If inflation keeps yields high, JPM and Goldman offer the more defensible earnings-supported trade.

Small caps are participating, but IWM’s lead looks more like a rate-sensitive rotation than a durable transfer of market leadership. If yields rise or earnings estimates keep falling, the breadth breakout can reverse while profitable large caps remain the tape’s anchor.

The July employment miss strengthens the case for rate-sensitive growth, but it is not a blanket bullish signal for financials. Lower rates may lift brokerage activity while slower hiring simultaneously pressures loan demand, margins, and credit quality at traditional banks.

June new-home sales improved, but the drop in builder confidence shows that volume is stabilizing before affordability or earnings. Price cuts, incentives and lower-priced product—not rate relief alone—will determine which builders can defend margins.

A Fed hold only helps long-duration growth if it points toward cuts, and current wage and inflation signals point the other way. With real yields high and valuation premiums intact, the setup favors JPM and GS over NEE, PLD, and AMT.

If the Fed stays more hawkish than equity investors want to admit, financials look like a cleaner macro expression than hiding in pricey defensives or reflexively buying every tech dip. Banks and insurers are not a recession-proof all-clear, but in a sticky-rate regime they offer cheaper cash flows, less duration risk, and a better chance to outperform by simply being less crowded.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime